Journal
FUTURE ONCOLOGY
Volume 11, Issue 10, Pages 1519-1530Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon.15.43
Keywords
breast cancer; chemotherapy; hepatectomy; liver metastases; metastasectomy; resection; survival; surgery
Categories
Ask authors/readers for more resources
Introduction: Liver metastases from breast cancer (BCLM) confer poor survival. Liver resection in BCLM patients has been increasingly employed. Aim: We undertook a systematic review to evaluate the role of hepatic resection in patients with breast cancer metastatic to the liver. Materials & methods: In total, 36 studies were overviewed. Patient populations, characteristics, morbidity, mortality and survival were documented. Results: Median overall survival was 41 months. Major morbidity was rare while 30-day postoperative mortality was near nil. Conclusion: Liver surgery for BCLM can be performed with low mortality, acceptable morbidity and promising survival benefit in carefully selected patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available